Johnson Shane Aaron 4/A
4/A · InMed Pharmaceuticals Inc. · Filed Nov 18, 2022
Insider Transaction Report
Form 4/AAmended
Johnson Shane Aaron
SVP, GM of BayMedica LLC
Transactions
- Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-11-14−4,200→ 3,800 totalExercise: $2.78Exp: 2027-11-13→ Common shares (4,200 underlying)
Footnotes (3)
- [F1]The options were granted on 11/14/2022 and will vest as follows: 25% of stock options will vest 6 months after the date of Grant; 25% of stock options will vest 12 months after the date of the Grant; 25% stock options will vest 18 months after the date of the Grant; and 25% stock options will vest 24 months after the date of the Grant.
- [F2]On September 7, 2022, the Issuer's common stock was reverse split on a 1-for-25 basis. This number reflects that reverse stock split.
- [F3]On November 14, 2022, the reporting person reported the grant of an employee stock option to buy 4,200 shares of the Issuer's common stock at an exercise price of $2.78 per share. Such employee stock option was issued in error and has been cancelled. As of November 18, 2022, the reporting person beneficially owns 3,800 derivative securities of the Issuer.